First Hawaiian Bank Buys 4,494 Shares of Humana Inc. (NYSE:HUM)

First Hawaiian Bank increased its stake in Humana Inc. (NYSE:HUM) by 55.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 12,647 shares of the insurance provider’s stock after buying an additional 4,494 shares during the period. First Hawaiian Bank’s holdings in Humana were worth $3,209,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. PDT Partners LLC boosted its stake in shares of Humana by 190.0% in the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after purchasing an additional 2,660 shares during the last quarter. Ontario Teachers Pension Plan Board boosted its position in Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after acquiring an additional 71,910 shares during the last quarter. Swedbank AB grew its holdings in Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after acquiring an additional 3,085 shares during the period. Wilmington Savings Fund Society FSB bought a new position in shares of Humana in the 3rd quarter worth about $948,000. Finally, Heritage Oak Wealth Advisors LLC acquired a new position in shares of Humana in the 2nd quarter valued at about $3,456,000. 92.38% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.32% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on HUM shares. Cantor Fitzgerald reiterated a “neutral” rating and issued a $395.00 target price on shares of Humana in a report on Tuesday, October 1st. Piper Sandler lowered shares of Humana from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $392.00 to $274.00 in a research note on Thursday, October 3rd. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a research note on Tuesday, October 8th. Oppenheimer decreased their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research note on Thursday, October 3rd. Finally, Leerink Partners cut shares of Humana from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $302.00.

Humana Stock Performance

Shares of NYSE HUM traded up $1.01 during midday trading on Wednesday, reaching $268.22. The company’s stock had a trading volume of 863,555 shares, compared to its average volume of 1,165,878. The stock has a market capitalization of $32.30 billion, a P/E ratio of 23.76, a PEG ratio of 2.12 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a 50 day moving average price of $272.82 and a 200-day moving average price of $312.17. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $462.08.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, equities analysts predict that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.32%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.